XML 76 R64.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share-based compensation and stockholders' equity - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense $ 5.5 $ 8.3 $ 11.4 $ 15.1
Cost of Commercial Product sales | Total Product sales, net        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 0.0 0.0 0.0 0.1
Cost of Commercial Product sales | MCM Product sales        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 0.6 1.2 1.3 2.5
Cost of Commercial Product sales | Total Bioservices revenues        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 0.2 0.3 0.3 0.6
R&D        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 0.5 0.4 1.0 1.1
Selling, general and administrative        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense $ 4.2 $ 6.4 $ 8.8 $ 10.8